Identification of a leukemic counterpart of the plasmacytoid dendritic cells

This work aims to demonstrate that CD4(+)CD56(+) malignancies arise from tr ansformed cells of the lymphoid-related plasmacytoid dendritic cell (pDC) s ubset. The analysis of malignant cells from 7 patients shows that in all ca ses, like pDCs, leukemic cells are negative for lineage markers CD3, CD19, CD13, CD33, and CD11c but express high levels of interleukin-3 receptor alp ha chain (IL-3R alpha), HLA-DR, and CD45RA. Tumor cells produce interferon- alpha in response to influenza virus, while upon maturation with IL-3 they become a powerful inducer of naive CD4(+) T-cell proliferation and promote their T-helper 2 polarization. As pDCs, leukemic cells also express pre-T a lpha and lambda-like 14.1 transcripts, arguing in favor of a lymphoid origi n. In addition, malignant cells express significant levels of CD56(+) and g ranzyme B. Overall, those observations suggest that CD4(+)CD56(+) leukemic cells could represent the malignant counterpart of pDCs, both of which are closely related to B, T, and NK cells. (Blood. 2001;97:3210-3217) (C) 2001 by The American Society of Hematology.